Pharmafile Logo
Pharmafocus logo
Advanced Search

Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia

February 1, 2023
Business Services

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …

News
Press release

ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization

February 1, 2023
Business Services

February 1, Utrecht, The Netherlands   ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest and most …

News
Press release

Germo Gericke, MD

February 1, 2023
Business Services

Dr. Gericke brings extensive experience in the research and development of radioligand therapies Appointment coincides with launch of Ariceum International …

Appointment

Sequana Medical announces grant of additional DSR® patent in United States

February 1, 2023
Business Services

Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medic

News
Press release

Neuraxpharm announces closing of acquisition of established products from Sanofi

February 1, 2023
Business Services

Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …

News
Press release

Dr Jean-Michel Cosséry

February 1, 2023
Business Services

Jean-Michel brings 25 years of experience in the international pharmaceutical and biotech industries both in an executive and non-executive capacity …

Appointment

COVID-19 treatments drive Pfizer’s annual earnings up to $100bn

February 1, 2023
Sales and Marketing

Big Pharma giant Pfizer’s annual earnings in 2022 reached $100bn, a considerable proportion of which came from its COVID-19 vaccine …

News

Adding veliparib to chemotherapy can extend progression-free survival in in some breast cancer patients

February 1, 2023
Research and Development

It appears that adding veliparib to chemotherapy can extend progression-free survival (PFS) in patients suffering from triple negative breast cancer …

News

NaDeNo’s nanomedicine delivery system inspires hope for peritoneal cancer

February 1, 2023
Research and Development

NaDeNo, a new nanomedicines company and spin-off of the Norwegian science institute SINTEF, has revealed promising results for its cure …

News

FDA approves Axonics’ neurostimulator

February 1, 2023
Medical Communications

US-based medtech company Axonics have received FDA approval for their fourth-generation, rechargeable sacral neuromodulation system for the treatment of chronic …

News

Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™

January 31, 2023
Business Services

Global healthcare and business consulting services provider Terebellum is launching a brand-new monthly Specialty Pharmaceutical Pulse™ insights bulletin in the …

News
Press release

Aptar Pharma releases recyclable nasal spray pump

January 31, 2023
Research and Development

US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal …

News

Amgen launches Amjevita biosimilar on US market

January 31, 2023
Medical Communications

Amgen’s Amjevita (adalimumab-atto) has just launched on the US market, meaning it becomes the first biosimilar to reference the blockbuster …

News

Johnson & Johnson subsidiary loses US bankruptcy bid

January 31, 2023
Medical Communications

A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) subsidiary’s bankruptcy petition, which aimed …

News

First Wave BioPharma announces phase 2 trial

January 31, 2023
Research and Development

Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of …

News

Dr. Lin Römer

January 31, 2023
Business Services

Munich, 31 January 2023 – Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today …

Appointment

Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa-cel

January 30, 2023
Business Services

London, UK and ZUG, Switzerland, January 27, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (NASDAQ: CRSP) today announced that …

News
Press release

BEXIMCO PHARMACEUTICALS LIMITED Half Year Results 2022-23

January 30, 2023
Business Services

Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP, LEI No.: 213800IMBBD6TIOQGB56), the fast-growing manufacturer of generic …

News
Press release

Kelso Pharma announces first product launch

January 30, 2023
Business Services

30th January 2023: Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the …

News
Press release

Pharmacists say England is not yet unlocking potential of self-care, with 77% backing the idea of a National Self-Care Strategy

January 30, 2023
Business Services

London, 30 January 2023. Today, a new report by Sanofi, an innovative global healthcare company, calls on the Government to …

News
Press release
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026